Gooden et al. analysed 149 cervical carcinoma patients for HLA-E expression [23]; and although the research did not focus on analysis of differences by histopathological subtypes, only 4/26 (15%) AC/ASC cases exhibited low expression of HLA-E compared to 29/123 (24%) of the SCC cases. The gene discussed is HLA-E; the disease is cervical carcinoma.